This inventor holds 20 USPTO granted patents and 1 published patent application, plus 7 CIPO patents and 5 EPO patents, primarily in Gene Editing Technology. Top assignees: Sangamo Biosciences, Inc., Sangamo Therapeutics, Inc., The University of Texas System. Active years: 2003-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Pablo, CA (US) (2003 - 2006)
- Novato, CA (US) (2007 - 2018)
- Richmond, CA (US) (2016 - 2021)
Company Filing History:
16 out of 160 
4 out of 154 
3 out of 5,640 
Years Active: 2003-2021
Areas of Expertise:
Title: The Innovations of Trevor Collingwood in Stem Cell Research
Introduction
Trevor Collingwood, an innovative inventor based in Novato, California, has made significant contributions to the field of stem cell research. With a remarkable portfolio of 20 patents, Collingwood has pioneered important methodologies that facilitate various applications of stem cells, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Among his latest groundbreaking patents is the modulation of stem cells using zinc finger proteins. This invention discloses methods and compositions for modifying stem cells utilizing one or more zinc finger proteins (ZFPs). These methods are invaluable for refining processes such as dedifferentiating cells, differentiating stem cells into the desired phenotype, propagating stem cells, and facilitating cloning. In addition, Collingwood's patent concerning the modification of a human leukocyte antigen (HLA) locus presents methods and compositions for modulating the expression of this locus or selectively deleting or manipulating HLA loci or regulators. This invention holds the potential for significant advancements in transplant science and immunology.
Career Highlights
Collingwood’s illustrious career includes key positions at leading biotechnology firms such as Sangamo Biosciences, Inc. and Sangamo Therapeutics, Inc. These companies have been instrumental in the development of innovative therapies that leverage gene editing and cell modification technologies. Trevor's work has not only led to the successful implementation of his inventions but has also contributed to the overall growth and competitiveness of the biotech industry.
Collaborations
Throughout his career, Trevor Collingwood has collaborated with notable scientists and researchers, including Fyodor Urnov and Alan P Wolffe. These collaborations emphasize the importance of teamwork and knowledge sharing in driving innovation forward. Their combined efforts have resulted in groundbreaking advancements in genetic engineering and stem cell therapies, further enhancing the impact of Collingwood's inventions.
Conclusion
Trevor Collingwood's contributions to stem cell science through his innovative patents and collaborations mark him as a prominent figure in the field. His ongoing research and commitment to developing novel methodologies for cell manipulation hold promise for the future of medical treatments. As the biotech industry continues to evolve, inventors like Trevor Collingwood play a crucial role in shaping the landscape of scientific progress.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile